Synergy, Obviousness, and Enablement: Key Takeaways from the Madras HC’s Amgen Decision
Understanding the Difference between Section 3(d) and 3(e) through Oramed
No Patent For Intermediates without Efficacy
Sowing the Seeds of Change: Patent Law, Biotechnology, and the Sakata Case
Crystallized Control: Unlocking the Secrets to Polymorph Patents
Delhi High Court Temporarily Injuncts Zydus Lifesciences from Selling Breast Cancer Drug
Post-Hearing Claim Amendments andSection 59: Key Insights from Recent Judgment
Amendments at PCT National Phase Entry: DHC in Mitsui Chemicals
Impact of the Draft Patents (Amendment) Rules, 2023 on the Pharmaceutical Sector and Public Health Safeguards